🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NTL
$NTLA
🔒 US EquitiesIntellia Therapeutics Inc
AVG HISTORICAL GAP
-1.12%
MAX GAP RECORD
-25.77%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NTLA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NTLA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (UNDETERMINED) |
+0.00%
|
| May 11, 2026 Earnings Release 2026-05-11 (BEFORE OPEN) |
-0.21%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN) |
+4.99%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-25.77%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
+1.32%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+8.02%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (UNDETERMINED) |
+0.00%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (UNDETERMINED) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.8%
Bullish Gaps (5)
Bearish Gaps (3)
Neutral / Flat (3)
📖 Intelligence Summary
Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗